Video Shorts

1:36
Semaglutide Misses Mark for Alzheimer Disease in evoke Trials
6 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:39
The Medical Sisterhood: Ways to Stay Organized
7 months ago
by
Amy Y. Chen, MD(+1 more)

1:30
Why ARNIs Were Excluded from POLY-HF
7 months ago
by
Ambarish Pandey, MD(+2 more)

1:08
The Medical Sisterhood: Balance and Boundaries in the Holiday Season
7 months ago
by
Mona Shahriari, MD, FAAD(+1 more)

1:12
Skin of Color Savvy: Hair-Care Challenges in Dermatology
7 months ago
by
Kayla Taylor, MD(+1 more)

1:07
POLY-HF's 50% Drop in Heart Failure Hospitalizations
7 months ago
by
Muthiah Vaduganathan, MD, MPH(+2 more)

0:59
Dupilumab Cuts Surgery Need in Patients with Allergic Fungal Rhinosinusitis
7 months ago
by
Amber Luong, MD, PhD

2:14
The Puzzle of Polypill Adherence
7 months ago
by
Muthiah Vaduganathan, MD, MPH(+2 more)

1:04
How to Differentiate Other Forms of Arthritis and Psoriatic Arthritis
7 months ago
by
Shikha Singla, MD

1:18
Kidney Week: DUPLEX Supports Safety of Sparsentan in Pediatric FSGS
7 months ago
by
Michelle Rheault, MD

1:08
Why Enlicitide Will Revolutionize Primary Care Prescribing
7 months ago
by
Ann Marie Navar, MD, PhD

0:46
Key Members of a Multidisciplinary Team in Heart Failure Care
7 months ago
by
David Landers, MD

1:03
AI Scribes Cut Doctor Burnout Within 30 Days
7 months ago
by
Lee Schwamm, MD

1:04
Simplifying Oral Semaglutide for Everyday Use
7 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:11
FDA Approves First Oral GLP-1 for Cardiovascular Health
7 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

0:46
Does Semaglutide Have Cardiovascular Benefits?
7 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

0:47
Why is the FDA Approval of Roflumilast Significant for Children with Eczema?
7 months ago
by
Lawrence Eichenfield, MD

1:06
Clinical Remission in Asthma Becomes an Achievable Goal
7 months ago
by
Linda Rogers, MD

1:12
Could Combination Therapy Be the Future of Hypertension?
7 months ago
by
Manish Saxena, MBBS

0:50
Why Drug Delivery Method Matters in PH-ILD
8 months ago
by
Kevin Kunzmann

0:43
A Banner Year for COPD
8 months ago
by
Nicola Hanania, MD, MS

1:19
Switching to Donidalorsen Cuts HAE Attacks by 65%
8 months ago
by
William Lumry, MD

1:11
How to Best Identify a Lung Cancer Screening Candidate
8 months ago
by
Douglas Wood, MD

0:44
Signs of Poor Air Quality Exposure at the Clinic
8 months ago
by
Sarath Raju, MD, MPH

0:45
Finding the Right Use of Catheter-Directed Therapy
8 months ago
by
Parth Rali, MD

0:25
Seeing the Whole Picture with New Pulmonary Embolism Trial Data
8 months ago
by
Parth Rali, MD

1:17
Santreva-ATK Crosses CTOs Without Damaging Blood Vessels
8 months ago
by
Subhash Banerjee, MD

1:24
Medical Ethics Unpacked: When Signed Donor Consent Clashes with Grieving Families
8 months ago
by
Steve Levine, MD(+2 more)

0:58
Biolinq Shine: The Future of Glucose Monitoring?
8 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:23
Weekly Insulin: A Game-Changer for Diabetes Management
8 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+2 more)
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
3
Machine Learning Model Predicts Type 2 Diabetes Risk Up To 10 Years Out
4
ACCESS: Aleniglipron Achieves Up To 11.3% Weight Loss in Phase 2b Obesity Trial
5
